These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18859181)

  • 1. The clinical use of hexaethyl tetraphosphate in myasthenia gravis; preliminary report.
    WESTERBERG MR; LUROS JT
    Univ Hosp Bull; 1948 Feb; 14(2):15. PubMed ID: 18859181
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of myasthenia gravis with octamethyl pyrophosphoramide (peptox III): a preliminary report.
    RIDER JA; SCHULMAN S; RICHTER R; MOELLER HC; DUBOIS KP
    AMA Arch Neurol Psychiatry; 1951 Aug; 66(2):111-2. PubMed ID: 14846437
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report.
    RIDER JA; SCHULMAN S; RICHTER RB; MOELLER HC; DUBOIS KP
    J Am Med Assoc; 1951 Mar; 145(13):967-72. PubMed ID: 14803293
    [No Abstract]   [Full Text] [Related]  

  • 4. Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.
    SCHULMAN S; RIDER JA; RICHTER RB
    AMA Arch Neurol Psychiatry; 1953 May; 69(5):643-6. PubMed ID: 13039628
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations of the effects of tetraethyl pyrophosphate in man, and on its use in the treatment of myasthenia gravis.
    GROB D; HARVEY AM
    Bull Johns Hopkins Hosp; 1949 Jun; 84(6):532-67. PubMed ID: 18151257
    [No Abstract]   [Full Text] [Related]  

  • 6. Tetraethyl pyrophosphate in the myasthenia gravis.
    NOVOTA OJ
    Mo Med; 1952 Feb; 49(2):133-4. PubMed ID: 14938938
    [No Abstract]   [Full Text] [Related]  

  • 7. Octamethyl pyrophosphoramide in the therapy of myasthenia gravis.
    GREGORY L; FUTCH ED; STONE CT
    Am J Med; 1952 Oct; 13(4):423-7. PubMed ID: 12985599
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations.
    SCHULMAN S; RIDER A; RICHTER RB
    J Am Med Assoc; 1953 Aug; 152(18):1707-11. PubMed ID: 13069246
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetra-ethylpyrophosphate in myasthenia gravis.
    BURGEN AS; KEELE CA; McALPINE D
    Lancet; 1948 Apr; 1(6501):519-21. PubMed ID: 18933790
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
    OSSERMAN KE; KAPLAN LI
    Ann Intern Med; 1954 Jul; 41(1):108-11. PubMed ID: 13171793
    [No Abstract]   [Full Text] [Related]  

  • 11. [About the pharmacological properties of some polyalkyl phosphates and their use in myasthenia gravis].
    KOELZER P; GIESEN J
    Arztl Forsch; 1949 Jan; 3(2):13-8. PubMed ID: 18116154
    [No Abstract]   [Full Text] [Related]  

  • 12. The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide.
    WILSON CW; WILLIAMS JP; MILLER DH
    Ann Intern Med; 1952 Sep; 37(3):574-9. PubMed ID: 12976955
    [No Abstract]   [Full Text] [Related]  

  • 13. Hexaethyl tetraphosphate as an insecticide.
    SIEGLER EH; HALL SA
    J Econ Entomol; 1947 Oct; 40(5):722-4. PubMed ID: 20271907
    [No Abstract]   [Full Text] [Related]  

  • 14. On the pharmacology of hexaethyl tetraphosphate.
    DAYRIT C; MANRY CH; SEEVERS MH
    J Pharmacol Exp Ther; 1948 Feb; 92(2):173-86. PubMed ID: 18903403
    [No Abstract]   [Full Text] [Related]  

  • 15. Eye muscles and myasthenia.
    Senanayake N
    Neurology; 1991 Sep; 41(9):1531. PubMed ID: 1891116
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetraethyl pyrophosphate and hexaethyl tetraphosphate.
    ROHWER SA; HALLER HL
    Pest Control; 1948 Aug; 16(8):12. PubMed ID: 18878641
    [No Abstract]   [Full Text] [Related]  

  • 17. The new insecticide hexaethyl tetraphosphate.
    SMITH FE
    Br Chem Dig; 1947 Nov; 2(2):51. PubMed ID: 18915690
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful use of sugammadex for caesarean section in a patient with myasthenia gravis.
    Soyoral L; Goktas U; Cegin MB; Baydi V
    Braz J Anesthesiol; 2017; 67(2):221-222. PubMed ID: 28236874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicological properties of hexaethyl tetraphosphate.
    HAGAN EC; WOODARD G
    Fed Proc; 1947; 6(1):335. PubMed ID: 20249580
    [No Abstract]   [Full Text] [Related]  

  • 20. Myasthenia gravis and associated autoimmune diseases in children.
    Tsao CY; Mendell JR; Lo WD; Luquette M; Rennebohm R
    J Child Neurol; 2000 Nov; 15(11):767-9. PubMed ID: 11108515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.